US Pre-Market SEC Filings Roundup — January 05, 2026

06-01-2026

Marblegate Capital Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003211, Size: 7 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on the core event, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling a potentially significant agreement and financial obligation.

06-01-2026

UMH Properties, Inc. filed a general filing (8-K) on January 6, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). No core event details, transaction values, financial metrics, or quantitative data are specified in the provided information. All specific impacts and numbers are NOT_DISCLOSED.

06-01-2026

Geron Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003388), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's terms, parties, value, or strategic context are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

Jackson Financial Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000968, Size: 3 MB), reporting under Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific transaction values, share counts, financial metrics, or other numerical details disclosed in the provided information. All quantitative data such as dollar values or percentages is NOT_DISCLOSED.

06-01-2026

Calumet, Inc. (/DE) filed Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003207, Size: 206 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, percentages, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

Company filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003148, Size: 244 KB) as a General Filing from us_sec, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, exhibits, company name, or sector are disclosed in the provided filing information. Event Type: General Filing.

06-01-2026

Athena Technology Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001373), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on merger/acquisition structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing summary. Sector not specified; all deal-related information is NOT_DISCLOSED.

06-01-2026

Steel Dynamics Inc filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-000833, Size: 253 KB) under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). This is a general filing from the US SEC with no sector specified. No specific details on the Regulation FD disclosure content or exhibits are provided in the filing summary.

06-01-2026

Twenty One Capital, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001442, Size: 196 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, appointment/resignation status, reasons, or quantitative data are provided in the summary.

06-01-2026

News Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001564708-26-000003, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the financial statements and exhibits are provided in the filing summary. Sector is not specified.

06-01-2026

IGC Pharma, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001185185-26-000032, size: 305 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. Sector not specified. No details on the agreement, transaction value, or other specifics provided.

06-01-2026

AMERICAN REBEL HOLDINGS INC filed a Form 8-K on January 06, 2026 (AccNo: 0001493152-26-000461, Size: 586 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or counterparties disclosed in the provided information. Core event involves a material agreement creating financial obligations and equity sales.

06-01-2026

Alussa Energy Acquisition Corp. II filed an 8-K on January 6, 2026 (AccNo: 0001213900-26-001319, Size: 265 KB) under Items 8.01 Other Events and 9.01 Financial Statements and Exhibits, announcing a Merger/Acquisition event. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

TPG Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003402, Size: 7 MB), reporting Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided summary. Core event involves unregistered equity sales and Regulation FD disclosure.

06-01-2026

American Drive Acquisition Co filed an 8-K on 2026-01-06 (AccNo: 0001104659-26-000809, Size: 420 KB) under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) related to a Merger/Acquisition event. No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

Kyndryl Holdings, Inc. filed an 8-K on January 06, 2026 (AccNo: 0001104659-26-001053, Size: 185 KB) disclosing Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer involved, position affected, reason for change, or any numerical data are provided in the available information. Sector is not specified.

06-01-2026

Compass Diversified Holdings filed a Form 8-K on January 6, 2026 (AccNo: 0001345126-26-000005, Size: 238 KB), reporting a delisting-related event under Item 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing) and Item 9.01 (Financial Statements and Exhibits). No specific details on the delisting reasons, transaction values, financial impacts, or other quantitative metrics are disclosed. Sector is not specified.

06-01-2026

Fidelity D & D Bancorp Inc filed a Form 8-K on 2026-01-06 (AccNo: 0001437749-26-000408, Size: 178 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Event occurred on January 06, 2026. No specific details on officer name, position, appointment/resignation, reason, or quantitative data provided.

06-01-2026

SmartKem, Inc. filed a Form 8-K on January 6, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-001067; File Size: 191 KB. No details on the specific event, transaction, or financial impacts are disclosed.

06-01-2026

Abpro Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001570, Size: 274 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, or financial metrics are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Alkermes plc filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003453), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with a file size of 204 KB; sector not specified. No core event details, transaction values, financial metrics, or named entities beyond the filer are explicitly stated.

06-01-2026

Genprex, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001437749-26-000437, Size: 173 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, or exhibits content are provided in the filing summary. Sector not specified.

06-01-2026

FRACTYL HEALTH, INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003452, Size: 632 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, board impacts, or quantitative data such as transaction values, share counts, or financial metrics are disclosed in the provided filing summary. All leadership, governance, succession, and market impact details are NOT_DISCLOSED.

06-01-2026

D-Wave Quantum Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001907982-26-000005, Size: 158 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for Regulation FD updates, with no core event, transaction details, or financial metrics specified. Sector not specified.

06-01-2026

Trinity Industries Inc filed a Form 8-K on January 6, 2026 (AccNo: 0000099780-26-000006, Size: 702 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, disclosures, transaction value, or financial impacts provided in the summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.

06-01-2026

ALUMIS INC. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001073, Size: 14 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Apogee Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001063, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financials, or other content are disclosed in the provided filing summary.

06-01-2026

Sunrun Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003449, Size: 1 MB), disclosing under Item 1.01 entry into a Material Definitive Agreement and under Item 2.03 creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. Item 9.01 includes Financial Statements and Exhibits. No transaction details, dollar values, or other quantitative data are provided in the filing summary.

06-01-2026

Energy Transfer LP filed a Form 8-K on January 06, 2026 (AccNo: 0001193125-26-003456, Size: 204 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This appears to be a voluntary disclosure of material nonpublic information with attached exhibits.

06-01-2026

AngioDynamics Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001140361-26-000341), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific quantitative data, transaction details, or financial metrics are mentioned in the provided filing information.

06-01-2026

McGraw Hill, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003463, Size: 420 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

06-01-2026

Sunoco LP filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003460, Size: 166 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, transaction, financials, or exhibits are provided in the filing summary. Sector not specified.

06-01-2026

Aclaris Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001076, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

06-01-2026

KALA BIO, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001829126-26-000055), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Sector is not specified.

06-01-2026

Realty Income Corp filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001089, Size: 369 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Six Flags Entertainment Corporation filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003472, Size: 268 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the core events, transactions, financial impacts, or quantitative data are disclosed in the provided filing summary. This is a multi-item general filing from the US SEC.

06-01-2026

Energy Vault Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001828536-26-000003, Size: 265 KB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or quantitative data are mentioned in the provided filing summary.

06-01-2026

Transcode Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001104659-26-001097, Size: 210 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure under Regulation FD, with no core event, transaction details, financial metrics, or named entities beyond the filer specified in the filing metadata. Sector is not specified.

06-01-2026

REPLIGEN CORP filed an 8-K on January 6, 2026 (AccNo: 0001193125-26-003467), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, reason for change, appointment/resignation status, or any quantitative data provided in the filing summary. Sector not specified.

06-01-2026

Milestone Pharmaceuticals Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001099, Size: 214 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative financial data, transaction values, and strategic impacts are NOT_DISCLOSED.

06-01-2026

Edible Garden AG Inc filed a Form 8-K on January 6, 2026 (AccNo: 0001477932-26-000041, size: 187 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. This appears to be a standard financial results disclosure.

06-01-2026

Archrock, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001091, Size: 267 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the Regulation FD disclosure content or exhibits are provided. Sector is not specified.

06-01-2026

Compass Digital Acquisition Corp. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000508, Size: 25 MB), disclosing a Merger/Acquisition event under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on deal structure, parties, valuation, or financial metrics are provided in the filing summary. Sector is not specified.

06-01-2026

Mineralys Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001933414-26-000002, Size: 173 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item general filing from the US SEC with no specific event details, transaction values, or financial metrics disclosed in the summary. Sector is not specified.

06-01-2026

HALLADOR ENERGY CO filed a Form 8-K on 2026-01-06 (AccNo: 0001104659-26-001098, Size: 191 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, appointment/resignation status, reasons, or timing are provided. Event classified as Officer Change; sector not specified.

06-01-2026

Denali Therapeutics Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001714899-26-000004, Size: 242 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other specifics are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Ainos, Inc. filed a Form 8-K on January 06, 2026, under Item 8.01 Other Events. Accession number: 0001493152-26-000517; file size: 244 KB. No details on the specific event, transaction, financials, or other quantitative data are provided.

06-01-2026

XBP Global Holdings, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001104659-26-001093, Size: 213 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

06-01-2026

Installed Building Products, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001628280-26-000785, Size: 249 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on the core event, transaction values, financial impacts, or other specifics are disclosed in the provided filing summary. This appears to be a multi-item filing involving Regulation FD compliance and attached exhibits.

06-01-2026

Dare Bioscience, Inc. filed an 8-K on January 6, 2026 (AccNo: 0001493152-26-000513, Size: 10 MB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, events, transactions, or financial metrics are provided in the filing summary. Sector not specified.

06-01-2026

Athene Holding Ltd. filed a Form 8-K on January 6, 2026 (AccNo: 0001527469-26-000004, size: 638 KB) reporting under Item 7.01 Regulation FD Disclosure. No details on the core event, transaction, financial impacts, or other specifics are disclosed in the provided filing metadata. Sector not specified.

06-01-2026

Compass Therapeutics, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001171843-26-000083, Size: 232 KB), disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific revenue, earnings, transaction values, or other quantitative metrics mentioned. Sector is not specified.

06-01-2026

Digi Power X Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001213900-26-001580, Size: 234 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of material non-public information and attachment of related exhibits. No specific details on the content of the disclosure, exhibits, transaction values, financial metrics, or other quantitative data are provided in the filing summary.

06-01-2026

NORTECH SYSTEMS INC filed a Form 8-K on 2026-01-06 (AccNo: 0001493152-26-000512, Size: 362 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

06-01-2026

Earth Science Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000511, size 242 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are provided. Sector is not specified.

06-01-2026

Wheeler Real Estate Investment Trust, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001527541-26-000004, Size: 205 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.

06-01-2026

Cyclerion Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003509, Size: 8 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with sector not specified. No quantitative data, transaction details, or other specifics disclosed in the provided information.

06-01-2026

Silexion Therapeutics Corp filed a Form 8-K on January 06, 2026 (AccNo: 0001178913-26-000067, Size: 283 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD.

06-01-2026

MOBIX LABS, INC filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000515, Size: 329 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.

06-01-2026

Galecto, Inc. filed a Form 8-K on 2026-01-06 (AccNo: 0001193125-26-003490, Size: 485 KB) disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Item 3.02 (Unregistered Sales of Equity Securities) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer position, name, appointment/resignation status, reasons, or quantitative data such as share counts or transaction values are provided. Sector is not specified.

06-01-2026

Aspire Biopharma Holdings, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001493152-26-000518, Size: 447 KB), reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific details on the agreement, transaction value, share count, or parties provided in the summary. All financial metrics, dollar values, and quantitative impacts are NOT_DISCLOSED.

06-01-2026

Atossa Therapeutics, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001193125-26-003506, Size: 209 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transactions, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with limited information available.

06-01-2026

eHealth, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001333493-26-000003), reporting multiple events including entry into (Item 1.01) and termination of (Item 1.02) material definitive agreements, creation of a direct financial obligation (Item 2.03), material modifications to rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed. Core events suggest significant corporate restructuring, but all key metrics are NOT_DISCLOSED.

06-01-2026

SS Innovations International, Inc. filed a Form 8-K on January 06, 2026 (AccNo: 0001213900-26-001594, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary.

06-01-2026

ESS Tech, Inc. filed a Form 8-K on January 6, 2026 (AccNo: 0001819438-26-000003, Size: 239 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason, or compensatory arrangements are provided in the filing summary. Sector not specified.